![]() ![]() Patients with renal or hepatic impairment The changeover should be undertaken under close medical supervision. In exceptional cases, where type 2 diabetic patients are regulated on insulin, a changeover to Glims may be indicated. Based on the response the Glims dosage may be increased stepwise, as indicated earlier. The recommended starting dose is 1 mg Glims per day. ![]() chlorpropamide), a wash out period of a few days is advisable in order to minimise the risk of hypoglycaemic reactions due to the additive effect. In some cases, especially in antidiabetics with a long half-life (e.g. For the switch over to Glims the strength and the half-life of the previous medicinal product has to be taken into account. Switch over from other oral hypoglycaemic agents to GlimsĪ switch over from other oral hypoglycaemic agents to Glims can generally be done. Change in dosage may also be necessary if there are changes in weight or life style of the patient, or other factors that increase the risk of hypo- or hyperglycaemia. ![]() To avoid hypoglycaemia timely dose reduction or cessation of therapy must therefore be considered. In the course of treatment, as an improvement in control of diabetes is associated with higher insulin sensitivity, Glims requirements may fall. ![]() If a patient has a hypoglycaemic reaction on 1 mg Glims daily, this indicates that they can be controlled by diet alone. If a dose is forgotten, this should not be corrected by increasing the next dose. It is recommended that this dose be taken shortly before or during a substantial breakfast or - if none is taken - shortly before or during the first main meal. Normally a single daily dose of Glims is sufficient. The combination therapy should be initiated under close medical supervision. While maintaining the Glims dose, insulin treatment is started at a low dose and titrated up depending on the desired level of metabolic control. In patients not adequately controlled with the maximum daily dose of Glims, concomitant insulin therapy can be initiated if necessary. While maintaining the metformin dose, the Glims therapy is started with a low dose, and is then titrated up depending on the desired level of metabolic control up to the maximum daily dose. In patients not adequately controlled with the maximum daily dose of metformin, concomitant Glims therapy can be initiated. The maximum recommended dose is 6 mg Glims per day. If control is unsatisfactory, the dosage should be increased, based on the glycaemic control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3, or 4 mg Glims per day.Ī dosage of more than 4 mg Glims per day gives better results only in exceptional cases. If good control is achieved, this dosage should be used for maintenance therapy.įor the different dosage regimens appropriate strengths are available. The dosage is determined by the results of blood and urinary glucose determinations. Tablets or insulin cannot compensate if the patient does not keep to the recommended diet. Instead, you should contact venue or IQPC staff via telephone so that we can ensure you receive testing, medical attention and whatever other assistance may be appropriate to ensure your safety and that of others around you.-We look forward to everyone enjoying a healthy, safe and productive event.The basis for successful treatment of diabetes is a good diet, regular physical activity, as well as routine checks of blood and urine. If you are feeling feverish, have a persistent cough, or are otherwise experiencing potential symptoms of Covid-19, please do not enter the event. By entering this event, you voluntarily assume all risks related to exposure to Covid-19.-We ask that every person at the event self-monitor for symptoms of illness before entering the event each day. Should you at any time have any questions or concerns regarding these protocols, please feel free to reach out to any IQPC staff member at the event.-Please note that an inherent risk of exposure to Covid-19 may exist in any public place where others are present. We will also rely on the good judgment and professionalism of our attendees to behave responsibly throughout the event and cooperate with the policies put in place for the benefit of all of our attendees. IQPC, its officers, directors, subsidiaries, and affiliates takes seriously the health and safety of our staff and of our clients, vendors, customers and guests. ![]()
0 Comments
Leave a Reply. |